Cardiovascular Imaging With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients With Fibroinflammatory Disorders

JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 2):365-368. doi: 10.1016/j.jcmg.2017.10.020.
No abstract available

Keywords: (18)F-FDG-PET/CTA; Erdheim Chester Disease; fibroinflammatory disorders; immunglobulin G4 related disease.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aortography / methods
  • Biopsy
  • Cardiovascular Diseases / diagnostic imaging*
  • Cardiovascular Diseases / immunology
  • Cardiovascular Diseases / pathology
  • Cardiovascular Diseases / therapy
  • Computed Tomography Angiography
  • Coronary Angiography
  • Erdheim-Chester Disease / diagnostic imaging*
  • Erdheim-Chester Disease / immunology
  • Erdheim-Chester Disease / pathology
  • Erdheim-Chester Disease / therapy
  • Female
  • Fibrosis
  • Fluorodeoxyglucose F18 / administration & dosage*
  • Humans
  • Immunoglobulin G4-Related Disease / diagnostic imaging*
  • Immunoglobulin G4-Related Disease / immunology
  • Immunoglobulin G4-Related Disease / pathology
  • Immunoglobulin G4-Related Disease / therapy
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Positron Emission Tomography Computed Tomography*
  • Predictive Value of Tests
  • Radiopharmaceuticals / administration & dosage*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18